[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality World wide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Kutzner A, Pramanik S, Kim PS, et al.All-or-(N)One - an epistemological characterization of the human tumorigenic neuronal paralogous FAM72 gene loci[J]. Genomics, 2015, 106(5): 278-285. [3] Yu Y, Wang Z, Zheng Q, et al.FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma[J]. Aging (Albany NY), 2021, 13(6): 8155-8176. [4] 仇秦威, 余丽华, 罗凯,等.微阵列芯片Meta 分析序列相似家族72 成员A mRNA水平与乳腺癌预后关系[J].广西医学, 2017, 39(05): 636-639. [5] Zhou Q, Chen L, Yang L, et al.Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma[J]. Front Oncol, 2022, 12: 1046473. [6] Heese K.The protein p17 signaling pathways in cancer[J]. Tumour Biol, 2013, 34(6): 4081-4087. [7] 萧正康, 马丹丹, 李中虎,等.基于多数据库分析FAM72A在肝癌中的表达及意义[J].安徽医科大学学报, 2020, 55(7): 1111-1117. [8] Nehar S, Mishra M, Heese K.Identification and Characterisation of the Novel Amyloid-Beta Peptide-Induced Protein P17[J]. FEBS Lett, 2009, 583(19): 3247-3253. [9] Benayoun BA, Pollina EA, Ucar D, et al.H3K4me3 Breadth is Linked to Cell Identity and Transcriptional Consistency[J]. Cell, 2014, 158(3): 673-688. [10] Li X, Chen X, Yuan Y, et al.Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study[J]. Front Oncol, 2022;12: 916947. [11] Chatonnet F, Pignarre A, Sérandour AA, et al.The hydroxymethylome of multiple myelomaidentifies FAM72D as a 1q21 marker linked to proliferation[J]. Haematologica,2020, 105(3): 774-783. [12] Garnelo M, Tan A, Her Z, et al.Interaction between tumour-infiltrating B cells and T cell scontrols the progression of hepatocellular carcinoma[J]. Gut, 2017,66(2): 342-351. |